Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Mechanistic effects of IVIg in neuroinflammatory diseases: conclusions based on clinicopathologic correlations.
[inclusion body myositis]
The
mechanisms
of
action
of
IVIg
on
immunoregulatory
and
neuroinflammatory
network
have
been
predominantly
based
on
in
vitro
experiments
and
animal
studies
,
rather
than
direct
effects
on
human
tissues
.
Based
on
clinicopathologic
correlations
and
tissues
obtained
before
and
after
IVIg
therapy
,
the
better
documented
and
clinically-relevant
in
-vivo
actions
of
IVIg
include
effects
on
:
a
)
Antibodies
.
An
extracted
antigen-
specific
anti-immunoglobulin
(
idiotypic
)
fraction
appears
partially
responsible
for
its
effect
in
myasthenia
gravis
and
GBS
;
b
)
Complement
.
Sera
from
Dermatomyositis
(
DM
)
patients
responding
to
IVIg
,
inhibit
complement
consumption
and
intercept
MAC
formation
leading
to
disappearance
of
MAC
deposits
in
the
repeated
muscle
biopsies
and
normalization
of
muscle
tissue
;
c
)
Genes
.
In
repeated
muscle
biopsies
from
DM
patients
who
improved
after
IVIg
,
but
not
from
Inclusion-
Body-
Myositis
(
IBM
)
who
did
not
improve
,
there
is
a
2
-
fold
alteration
of
2206
tissue
genes
associated
with
inflammation
,
fibrosis
,
tissue
remodeling
and
regeneration
;
and
d
)
degenerative-proinflammatory
molecules
and
β-amyloid
,
implicated
in
neurodegenerative
CNS
diseases
and
IBM
.
In
repeated
muscle
biopsies
of
IBM
patients
who
did
not
respond
to
IVIg
,
the
mRNA
or
protein
expression
for
chemokines
,
IFN-γ
,
TGF-ß
,
IL
-
10
,
Ubiquitin
and
aB-crystallin
is
reduced
,
but
not
for
the
key
molecules
ICOS
,
ICOSL
,
IL
-
6
,
IL
1
-
β
,
perforin
,
APP
,
nitric
oxide
synthase
and
nitrotyrosine
,
in
spite
of
good
IVIg
penetration
in
muscles
.
Collectively
,
the
selective
effectiveness
of
IVIg
in
human
diseases
seems
to
correlate
in
vivo
with
inhibition
of
causative
inflammatory
mediators
.
Study
of
accessible
tissues
before
and
after
therapy
and
clinicopathologic
correlations
,
may
help
explain
the
differential
effect
of
IVIg
in
autoimmune
or
neuroinflammatory
diseases
.
Diseases
Validation
Diseases presenting
"normalization of muscle tissue"
symptom
inclusion body myositis
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom